Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

84.48 -2.42 (-2.78%)

Delayed Quote Updated: 11:01 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

50 51 Next >

2 Healthcare Stocks to Buy Hand Over Fist in January ↗

January 16, 2025

Via The Motley Fool

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook

January 13, 2025

From DexCom, Inc.

Via Business Wire

Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market. ↗

January 09, 2025

Smart rings are one of the hottest consumer electronics categories, as evidenced by exhibitors at CES 2025. Oura leads the market.

Via Investor's Business Daily

3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025 ↗

January 08, 2025

Via The Motley Fool

Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From DexCom, Inc.

Via Business Wire

NASDAQ:DXCM qualifies as a high growth stock and is consolidating. ↗

December 25, 2024

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

1 Reason to Sell DexCom Stock, and 1 Reason to Buy ↗

December 21, 2024

Via The Motley Fool

These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024 ↗

January 04, 2025

Via The Motley Fool

DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM

December 21, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

December 17, 2024

From DexCom, Inc.

Via Business Wire

Peering Into DexCom's Recent Short Interest ↗

December 16, 2024

Via Benzinga

Key Takeaways From DexCom Analyst Ratings ↗

December 09, 2024

Via Benzinga

3 Reasons to Buy DexCom Stock Like There's No Tomorrow ↗

December 02, 2024

Via The Motley Fool

Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout. ↗

December 02, 2024

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

2 Excellent Healthcare Stocks to Hold Through the Next Decade ↗

November 28, 2024

Via The Motley Fool

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over ↗

November 26, 2024

Via The Motley Fool

2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest ↗

November 24, 2024

Via The Motley Fool

Dexcom and ŌURA Announce Strategic Partnership

November 19, 2024

From DexCom, Inc.

Via Business Wire

NASDAQ:DXCM qualifies as a high growth stock and is consolidating. ↗

November 11, 2024

Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

Large-Cap Stocks In Trouble - Sunday, Nov. 17 ↗

November 17, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom ↗

November 14, 2024

Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest Form 13F on Thursday and disclosed its trading activity from the prior quarter.

Via Benzinga

Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day

November 14, 2024

From DexCom, Inc.

Via Business Wire

Analyst Expectations For DexCom's Future ↗

October 25, 2024

Via Benzinga

These Analysts Revise Their Forecasts On DexCom Following Q3 Results ↗

October 25, 2024

Via Benzinga

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues ↗

November 08, 2024

Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.

Via Investor's Business Daily

1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years ↗

November 08, 2024

This medical device company is down but not out.

Via The Motley Fool

Why DexCom Stock Flopped on Friday ↗

October 25, 2024

Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.

Via The Motley Fool

Nasdaq Up Triple Digits As Stocks Rally, Yields Cool ↗

October 25, 2024

Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses.

Via Talk Markets

Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday? ↗

October 25, 2024

Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks.

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.